Community-Associated Methicillin-ResistantStaphylococcus aureusin a Pediatric Emergency Department in Newfoundland and Labrador
Author(s) -
Erin R. Peebles,
Robert Morris,
Roger Chafe
Publication year - 2014
Publication title -
canadian journal of infectious diseases and medical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.634
H-Index - 38
eISSN - 1918-1493
pISSN - 1712-9532
DOI - 10.1155/2014/267901
Subject(s) - medicine , impetigo , cellulitis , emergency department , staphylococcus aureus , methicillin resistant staphylococcus aureus , incidence (geometry) , cephalosporin , antibiotics , staphylococcal skin infections , skin infection , population , pediatrics , dermatology , microbiology and biotechnology , physics , environmental health , psychiatry , biology , bacteria , optics , genetics
First-generation cephalosporins and antistaphylococcal penicillins are typically the first choice for treating skin and soft tissue infections (SSTI), but are not effective for infections caused by methicillin-resistant Staphylococcus aureus (MRSA). It is currently unclear what percentage of SSTIs is caused by community-associated MRSA in different regions in Canada.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom